Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04949100 · ClinicalTrials.gov registry record · NA
Microcurrent for Fibromyalgia
A NA study of Fibromyalgia, sponsored by Paul Crawford.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04949100: Active NA study of Fibromyalgia, sponsored by Paul Crawford.
NCT04949100 is a NA study of Fibromyalgia that is active but no longer recruiting, run by Paul Crawford. The registered enrollment target is 50 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04949100, a NA study of Fibromyalgia, is active but no longer recruiting, sponsored by Paul Crawford.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Explore the use of microcurrent therapy for fibromyalgia patients and evaluate its effect on generalized pain and quality of life. Determine if microcurrent therapy be effectively self-administered by the patient as an adjunct to medical pain management.
Primary Outcome
The FIQR assesses three domains (function, overall impact and symptoms) from which a total score of pain impact is derived. FMS patients have a mean (SD) total score of 56.6 (19.9) and healthy patients have a mean (SD) total score of 12.1 (11.6). FMS patients' means for function, overall impact and symptoms domains are 15.6, 11.0, and 30.0 respectively. Higher total scores are indicative of greater dysfunction or symptom severity. While total scores are slightly negatively skewed favoring severe
Conditions Studied
Interventions
- DEVICE Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief
- DEVICE PLACEBO Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief
Study Locations (1)
Nevada
- Mike O'Callaghan Military Medical Center - Nellis Air Force Base
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2026-07 |
| Phase | NA |
What the registry record for NCT04949100 still lists
NCT04949100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief is the first listed.
NCT04949100 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT04949100 about?
NCT04949100 is a clinical study titled "Microcurrent for Fibromyalgia". Explore the use of microcurrent therapy for fibromyalgia patients and evaluate its effect on generalized pain and quality of life. Determine if microcurrent therapy be effectively self-administered by the patient as an adjunct to medical pain management.
What is the current status of trial NCT04949100?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-10-25. Estimated completion is 2026-07.
What conditions does trial NCT04949100 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT04949100?
The interventions under investigation include: Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief (DEVICE), PLACEBO Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief (DEVICE).
Who is sponsoring clinical trial NCT04949100?
This trial is sponsored by Paul Crawford, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04949100 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04949100's enrollment target sits among peer trials
50 49th of 76 higher than 27 of 76 other Fibromyalgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Effects of Breathing and Attention Training (BAT) on Pain Modulation
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Fibromyalgia Sleep A to ZZZ Study
RECRUITING · NA
-
Explosive Synchronization of Brain Network Activity in Chronic Pain
RECRUITING · NA
-
Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI